Myeloma Center
January 19, 2021
UAMS Myeloma Center Social Work Manager Appointed to National Board
LITTLE ROCK — The Board of Oncology Social Work Certification (BOSWC) recently chose Harold Dean, LCSW, OCW-C, clinical social work program manager for the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) to serve on its board. Dean will serve for three years. The BOSWC, established in 2003, promotes excellence in psychosocial…
December 9, 2020
Myeloma Survivor Grateful for Time with Grandchildren
Linda Cancienne of Alabaster, Alabama, and her husband, Mike, recently celebrated their 55th wedding anniversary by gathering with family around a backyard fire pit, socially distancing and wearing masks. “We went to our daughter’s house and enjoyed being together and recalling good memories,” Cancienne said. “I sure do miss hugging, though.” There was a time…
December 7, 2020
UAMS Physician Establishes Second International Guidelines for Treating Castleman Disease
LITTLE ROCK — Frits van Rhee, M.D., Ph.D., a myeloma researcher and clinician at the University of Arkansas for Medical Sciences (UAMS), was lead author on a recently published paper that establishes consensus diagnosis and treatment guidelines for a form of Castleman disease, a rare disorder of the lymph nodes and related tissues. The recommendations…
November 13, 2020
State-of-the-Art Infusion Center Opens at UAMS Winthrop P. Rockefeller Cancer Institute
A new center for patients undergoing chemotherapy was unveiled today at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute.
October 12, 2020
Social Work Manager: Being Social and Safe During the Holidays
“Wearing a mask is not a political statement,” said Harold Dean, LCSW, OSW-C, clinical social work program manager for the UAMS Myeloma Center. “Instead, it is a matter of public safety,” he told blood cancer patients during a recent virtual support group meeting. Dean is co-facilitator for the Leukemia and Lymphoma Society – Arkansas Division’s…
September 21, 2020
Retired UAMS HR Chief Shares Myeloma Journey through Blog
Hosea Long of Little Rock recently turned 70, a milestone that for most may seem unremarkable. After all, it was not the former UAMS employee’s 100th, 90th or even his 80th birthday. But it was inspiring and incredible for him and his loved ones. Long explained why in a recent entry titled “Tomorrow starts a…
September 16, 2020
UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients
LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…
September 14, 2020
UAMS Partners Card Offers Shoppers and Diners 20% Discount at About 200 Locations
About 200 shops and restaurants in central and northwest Arkansas and Conway will offer discounts Oct. 30 – Nov. 8 with Partners Card, a fundraising project of the volunteer auxiliary of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS).
August 28, 2020
Frits van Rhee, M.D., Ph.D., Named Cancer Institute Auxiliary Distinguished Honoree
From the safety and comfort of their homes, 46 guests gathered at their computers Aug. 21 to recognize one of the UAMS Winthrop P. Rockefeller Cancer Institute’s highly respected physicians: Frits van Rhee, M.D., Ph.D. At the virtual reception, van Rhee was presented with the Distinguished Honoree Award, a presentation made annually by the Cancer…
July 23, 2020
Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research
LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…
Next page